Rahul Ballal is the founder of Imara. Imara has raised $250M in total funding. Latest round: Series B. Backed by NEA, Pfizer Venture Investments.
Rahul D. Ballal, Ph.D., is the Chief Executive Officer of Imara Inc., a clinical-stage biopharma company focusing on rare hemoglobin disorders. He joined Imara after its launch with financing from investors such as NEA and Pfizer Venture Investments. Ballal has a background in the biotechnology sector, including executive roles.
Full founder directory · Investor directory · Company funding database · Fundraising library